Applications

One AI platform.
Every neutron-driven application.

Our spectrum-shaping AI works wherever neutrons meet target nuclei. The physics is universal. The market opportunity starts with medical isotopes — and expands into every sector that depends on neutron reactions.

People are dying on waitlists because we can't make isotopes fast enough. The bottleneck isn't reactors. It's physics.
Medical

Radiopharmaceuticals & Medical Isotopes

The radiopharmaceutical market is in a historic moment. $15B+ in big pharma acquisitions in two years. The first blockbuster radiopharmaceutical ever. A supply crisis that worsens with every FDA approval. And zero companies designing the neutron spectrum.

$12B+
Radiopharmaceutical market today
20%
CAGR — fastest-growing drug class
$15B+
Pharma M&A in radioisotopes (2 yrs)
40K+
US procedures/day — zero domestic Mo‑99

Pluvicto broke the dam

Novartis's Lu-177 radioligand therapy hit $1.39B revenue in 2024 (+42% YoY), targeting $5B peak. First blockbuster radiopharmaceutical ever. Now every major pharma company is racing to build a radioisotope pipeline — and they all need the same scarce neutron-produced isotopes.

Every FDA approval multiplies demand. New reactors take a decade and $1B+. Spectrum shaping multiplies the output of what already exists — in weeks, not years.

Bristol-Myers Squibb
$4.1B
RayzeBio — Ac-225 platform
AstraZeneca
$2.4B
Fusion Pharmaceuticals
Eli Lilly
$2.5B
Point Biopharma + Aktis
Novartis
$4.7B+
Mariana + PeptiDream + others
Sanofi
$356M
RadioMedix licensing
Total Firepower
$1.3T
Top 25 pharma (all-time high)
Neutron-produced isotopes we optimize

Some isotopes (F-18, Ga-68) are best made by cyclotrons that tune proton energy directly. We optimize neutron-driven production — the majority of commercial volume.

Mo-99 / Tc-99m

Molybdenum-99

80% of all nuclear medicine

40,000 daily US procedures depend on 5 aging reactors, none in America. The 2024 shortage canceled procedures globally. The single most critical isotope on Earth.

Lu-177

Lutetium-177

$3.4B → $14.7B (2034)

Powers Pluvicto and Lutathera. 20% CAGR. Every pharma company wants in. Neutron capture on Yb-176 — production already strained.

Co-60 / Ir-192

Industrial workhorses

Sterilization + brachytherapy

Co-60 sterilizes 40% of single-use medical devices globally. Ir-192 treats 500K+ cancer patients/year. Both made exclusively by neutron capture.

You don't need massive flux
if you use the flux intelligently.
Energy

Fusion Tritium Breeding

Every D-T fusion reactor must breed its own tritium fuel — there is no natural supply. Lithium blankets surrounding the plasma capture neutrons to produce tritium, but the breeding ratio is razor-thin. Most reactor designs barely achieve a tritium breeding ratio (TBR) above 1.0.

Our AI optimizes the neutron spectrum hitting the breeding blanket — maximizing tritium yield from the same fusion neutron source. The physics is identical: reshape φ(E) to overlap with the Li-6 and Li-7 capture cross-sections. A few percent improvement in TBR can mean the difference between a reactor that sustains itself and one that can't.

The tritium challenge
World tritium supply~25 kg
ITER annual need~0.4 kg
Commercial reactor need~55 kg/yr
Required TBR>1.05
Every fusion company on Earth needs to solve this. Same AI. Different target nucleus.
Defense

Radiation Effects Testing

Every satellite, every weapons system, every piece of space electronics must be certified against radiation damage. Current testing uses broad-spectrum neutron beams that don't match the actual threat environment — leading to over-engineering or missed failure modes.

AI-shaped neutron spectra can replicate specific threat profiles with precision: the exact energy distribution of cosmic ray secondaries, nuclear weapon effects, or reactor environments. DOD and NASA need this. The testing infrastructure exists — it just needs smarter beams.

Key applications
Space Electronics
Replicate LEO/GEO radiation environments for satellite qualification
Weapons Effects
Simulate nuclear weapon neutron spectra for hardening verification
Materials Science
Accelerated aging studies with tailored neutron damage profiles
Industrial

NTD Silicon & Transmutation

Neutron Transmutation Doping (NTD) is the gold standard for producing ultra-uniform silicon used in high-power electronics — from EVs to grid infrastructure. A thermal neutron converts Si-30 to P-31, creating perfectly homogeneous n-type doping that no chemical process can match.

The precision of the thermal spectrum directly determines doping uniformity. Our AI designs filter geometries that deliver exactly the thermal distribution needed — reducing waste irradiation and improving yield. The same approach applies to nuclear waste transmutation, where specific actinides must be targeted at their resonance energies.

NTD silicon market
Power semiconductor market$26B+
NTD share of high-power Si~90%
EV demand CAGR18%
Every IGBT in every EV inverter started as NTD silicon. Better spectra = better chips.
Why Compact Sources

The smaller the source, the more each neutron matters

SOURCE FLUX (n/cm²/s) → RESONANT VALUE → COMPACT FUSION 10¹³ n/cm²/s ACCELERATOR 10¹&sup4; n/cm²/s RESEARCH REACTOR 10¹&sup5; n/cm²/s
Countries face a choice: £500M for a reactor, or £25–200M for compact sources with 100× fewer neutrons. The missing insight: you don't need massive flux if you use the flux intelligently.
Validated by Science

The physics is proven.

Nature 2021

Geometry = 10× variation

Small changes in material arrangement produce order-of-magnitude differences in beam quality.

Grenoble 2025

"Unprecedented" AI geometries

Topology optimization found designs no human ever considered, beating decades of manual work.

Rong 2024

Neural net beats all

ML surrogate + genetic algorithm outperformed every previous manual design.

We don't build reactors.
We make every neutron source 10× more productive.

Wherever neutrons meet target nuclei, the spectrum determines the outcome.

Get in Touch